Early in December, as the house of cards that is Anil Potti‘s publication record started to really collapse, we called attention to a paper in The Lancet Oncology that had already been the subject of a correction and Expression of Concern in July of last year. Today, the journal officially retracted the paper, “Validation of … Continue reading Lancet Oncology retracts previously questioned Anil Potti paper
A prominent cancer research lab is up to three retractions and six corrections for “highly similar” images in papers published between 2018 and 2022. The lab is led by Kounosuke Watabe at Wake Forest University School of Medicine in Winston-Salem, North Carolina. Watabe holds one of three Wake Forest professorships all funded by a $2.8 … Continue reading Wake Forest cancer lab blames ‘honest mistakes’ for retractions
Our list of retracted or withdrawn COVID-19 papers is up past 500. There are more than 60,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately … Continue reading Weekend reads: Problematic papers prompt submission pause; HHS walks back Springer Nature cancellation; and hidden prompts for positive peer reviews
Our list of retracted or withdrawn COVID-19 papers is up past 500. There are more than 60,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately … Continue reading Weekend reads: Nobel Prize winners and retractions; Nature to publish peer reviews automatically; ‘AI or Die’?
Our list of retracted or withdrawn COVID-19 papers is up past 500. There are more than 60,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately … Continue reading Weekend reads: Journals are MAGA’s ‘latest target’; a psychedelic retraction; professor sues rival over plagiarism accusations
Our list of retracted or withdrawn COVID-19 papers is up past 500. There are more than 59,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately … Continue reading Weekend reads: MAHA report cites nonexistent studies; RFK Jr. threatens publishing access; can ‘zombie papers’ be killed?
Investigative journalist Charles Piller’s latest book, Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s, came out in February. It details the work of Matthew Schrag, a neurologist at Vanderbilt University in Nashville, Tenn., and other sleuths who uncovered evidence of problems in hundreds of research papers about the neurologic condition. Most reviews … Continue reading ‘More of the same’: Journals, trade website refuse to correct critiques of book on Alzheimer’s fraud
Our list of retracted or withdrawn COVID-19 papers is up past 500. There are more than 59,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately … Continue reading Weekend reads: Majorana manipulation allegations; Norway’s most-published researcher committed misconduct; ‘second chance’ for convicted Harvard chemist
Our list of retracted or withdrawn COVID-19 papers is up past 500. There are more than 58,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately … Continue reading Weekend reads: Journal halts submissions, citing NIH cuts; rejected paper published by ‘mistake’; feds cancel grant amid misconduct allegations
A correction to a clinical trial on a potential treatment for COVID-19 has taken more than a year — and counting — to get published. In the meantime, the article remains marked with an expression of concern that appeared in February 2024. The Lancet Regional Health–Americas published the study, a randomized clinical trial of the … Continue reading Why has it taken more than a year to correct a COVID-19 paper?